Last updated: August 7, 2025
Overview of Patent KR102489453
Patent KR102489453 pertains to a pharmaceutical innovation registered in South Korea. While comprehensive details require access to the full patent document, typical analysis involves dissecting the patent's claims, scope, and its position within the broader patent landscape. This patent likely relates to a novel drug compound, formulation, or method of treatment, given its cataloging within the Korean patent system.
Scope of Patent KR102489453
The scope of a patent determines the legal boundaries of the inventor’s rights and encompasses the extent of protection conferred. For KR102489453, the scope hinges primarily on the language used in its claims.
Claims Analysis
-
Independent Claims: These set the broadest boundaries, defining the core innovation. For a pharmaceutical patent, this could encompass a specific chemical entity, a composition, or a method of use.
-
Dependent Claims: Further narrow down the protection, adding specific features such as particular embodiments, formulations, or conditions.
Without direct access to the patent text, typical claims in a drug patent may include:
-
Chemical Composition Claims: Covering a novel active pharmaceutical ingredient (API) or a specific combination of APIs.
-
Method of Treatment: Claims targeting therapeutic methods, for instance, administering the compound for treating a particular disease.
-
Formulation Claims: Covering specific formulations, delivery systems, or dosage forms.
The scope largely depends on how broadly the claims are drafted. Broader claims could cover multiple therapeutic uses or structurally similar compounds, whereas narrower claims focus on specific compounds or formulations.
Patent Landscape for KR102489453
The patent landscape involves analyzing prior art, related patents, and competitive filings to understand the strength and value of KR102489453.
Prior Art and Novelty
-
Novelty: The patent’s claims must demonstrate novelty over existing compounds, therapies, or formulations. Prior art searches can reveal overlapping patents or published literature.
-
Inventive Step: The patent must show an inventive step beyond prior art, e.g., unexpected efficacy, improved stability, or reduced side effects.
-
Availability in Patent Databases: A search in WIPO, Korean Intellectual Property Office (KIPO), and global patent databases indicates whether similar patents exist and how KR102489453 differentiates itself.
Related Patents and Patent Families
-
The patent landscape includes global family members, especially in jurisdictions like China, Japan, and the US, where drug patents are crucial for international commercialization.
-
If similar patents cover the same target indication or compound class, KR102489453's strength may depend on claim breadth and priority dates.
Competitive Positioning
-
Patent Clusters: In the therapeutic area (e.g., oncology, neurology), multiple patents may cover different aspects of similar compounds or targets.
-
Freedom-to-Operate (FTO): Assessing whether KR102489453 infringes or is infringed upon by existing patents guides commercialization potential.
Legal and Strategic Implications
-
Strengthening with Patent Family Extensions: Application filings in key jurisdictions could bolster its global patent portfolio.
-
Potential Challenges: Existing patents from competitors or prior art references could be grounds for invalidation, underscoring the importance of claim language and patent prosecution strategy.
-
Expiry and Lifecycle: Typically, patents filed around 2020 would expire in 2037–2040, considering patent term extensions for drugs. The patent's lifecycle affects market exclusivity and licensing opportunities.
Conclusion
KR102489453 appears to be a strategically significant patent within South Korea's pharmaceutical IP landscape. Its scope, centered around specific claims related to drug composition or therapeutic methods, positions it as a potentially strong barrier to competitors, provided the claims are broad and well-supported by prior art.
The patent landscape encompasses a broad network of related filings, emphasizing the importance of comprehensive patent strategy for global protection. Its strength and longevity depend on continued prosecution, potential opposition, and harmonization with international patent filings.
Key Takeaways
- The patent’s claim breadth is critical; broader claims offer stronger protection but must withstand validity challenges.
- Positioning within the patent landscape influences licensing and commercialization strategies.
- A thorough prior art and patent family analysis enhances understanding of the patent’s robustness.
- Strategic international filings can amplify the patent’s value beyond Korea.
- Vigilance against potential infringement or invalidation actions remains essential for ongoing protection.
FAQs
Q1: How can I determine the scope of claims in KR102489453 without the full patent document?
A1: Access the official patent database (e.g., KIPO or Espacenet) to review the published patent document, focusing on the claims section for precise scope; legal professionals can assist in interpretation.
Q2: What factors influence the strength of a pharmaceutical patent like KR102489453?
A2: Key factors include claim breadth, novelty over prior art, inventive step, filing and priority dates, and the robustness of prosecution proceedings.
Q3: How does the patent landscape affect the commercialization of drugs protected by KR102489453?
A3: A dense patent landscape may restrict freedom-to-operate, necessitating licensing negotiations or development of alternative pathways. Clear IP positioning is essential for maximizing market potential.
Q4: Can KR102489453 be challenged or invalidated?
A4: Yes, competitors or third parties may challenge the patent via opposition or invalidity proceedings, especially if prior art reveals overlapping inventions or the claims are overly broad.
Q5: What is the process for extending the patent protection internationally?
A5: Strategy involves filing Patent Cooperation Treaty (PCT) applications, followed by regional or national phase entries in key jurisdictions, to extend protection globally.
Sources:
[1] Korean Intellectual Property Office (KIPO) Patent Database.
[2] WIPO PATENTSCOPE Database.
[3] Pharmaceutical patent strategy literature and case studies.
[4] Global patent landscapes in pharmaceutical innovations.
